Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan P Venook

Showing results (81-90 of 246) with videos related to

Pageof 25
Sort By:
Journal of Clinical Nutrition and Food Science|August 20, 2019
Vitamin D Levels in Patients with Colorectal Cancer and Matched Household MembersMarissa B Savoie, Alan Paciorek, Li Zhang, et al.
Gastrointestinal Cancer Research : GCR|May 23, 2009
A Phase II Study of Long-Acting Octreotide in Patients With Advanced Hepatocellular Carcinoma and CLIP Score of 3 or HigherUsman Shah, Bert O'Neil, Jill Allen, et al.
Radiology|December 26, 2003
Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patientsMark W Wilson, Robert K Kerlan, Nicholas A Fidelman, et al.
The American Journal of Gastroenterology|July 10, 2007
Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosisRichard K Sterling, Lennox Jeffers, Fredric Gordon, et al.
BMC Cancer|December 13, 2022
Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with <sup>90</sup>Y resin microspheres for chemo-refractory colorectal liver metastasesNicholas Fidelman, Chloe E Atreya, Madeline Griffith, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2014
International adaptations of NCCN Clinical Practice Guidelines in OncologyRobert W Carlson, Jonathan K Larsen, Joan McClure, et al.
Pancreas|July 12, 2012
Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patientsJustin R Parekh, Sam C Wang, Emily K Bergsland, et al.
Archives of Surgery (Chicago, Ill. : 1960)|March 17, 2010
Identification of unknown primary tumors in patients with neuroendocrine liver metastasesSam C Wang, Justin R Parekh, Marlene B Zuraek, et al.
Journal of the National Cancer Institute|August 29, 2012
When progressive disease does not mean treatment failure: reconsidering the criteria for progressionGeoffrey R Oxnard, Michael J Morris, F Stephen Hodi, et al.
Clinical Colorectal Cancer|June 8, 2007
Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinomaAlan P Venook, Charles D Blanke, Donna Niedzwiecki, et al.
Pageof 25

Showing results (81-90 of 246) with videos related to

Sort By:
Pageof 25
Journal of Clinical Nutrition and Food Science|August 20, 2019
Vitamin D Levels in Patients with Colorectal Cancer and Matched Household MembersMarissa B Savoie, Alan Paciorek, Li Zhang, et al.
Gastrointestinal Cancer Research : GCR|May 23, 2009
A Phase II Study of Long-Acting Octreotide in Patients With Advanced Hepatocellular Carcinoma and CLIP Score of 3 or HigherUsman Shah, Bert O'Neil, Jill Allen, et al.
Radiology|December 26, 2003
Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patientsMark W Wilson, Robert K Kerlan, Nicholas A Fidelman, et al.
The American Journal of Gastroenterology|July 10, 2007
Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosisRichard K Sterling, Lennox Jeffers, Fredric Gordon, et al.
BMC Cancer|December 13, 2022
Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with <sup>90</sup>Y resin microspheres for chemo-refractory colorectal liver metastasesNicholas Fidelman, Chloe E Atreya, Madeline Griffith, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2014
International adaptations of NCCN Clinical Practice Guidelines in OncologyRobert W Carlson, Jonathan K Larsen, Joan McClure, et al.
Pancreas|July 12, 2012
Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patientsJustin R Parekh, Sam C Wang, Emily K Bergsland, et al.
Archives of Surgery (Chicago, Ill. : 1960)|March 17, 2010
Identification of unknown primary tumors in patients with neuroendocrine liver metastasesSam C Wang, Justin R Parekh, Marlene B Zuraek, et al.
Journal of the National Cancer Institute|August 29, 2012
When progressive disease does not mean treatment failure: reconsidering the criteria for progressionGeoffrey R Oxnard, Michael J Morris, F Stephen Hodi, et al.
Clinical Colorectal Cancer|June 8, 2007
Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinomaAlan P Venook, Charles D Blanke, Donna Niedzwiecki, et al.
Pageof 25